Followers

Thursday, November 17, 2011

FDA Yanks Avastin Breast Cancer Indication

FDA Yanks Avastin Breast Cancer Indication WASHINGTON -- The FDA has announced that bevacizumab (Avastin) is no longer approved for the treatment of breast cancer. The Genentech drug retains its indications for colon, lung, ... FDA Yanks Avastin Breast Cancer Indication

No comments:

Post a Comment

Popular Posts